Analysis of genotoxic impurities in pharmaceuticals

Application note | 001041 Pharma A validated LC-HRAM-MS method for the rapid and confident determination of azido (AZBT) impurity in sartan drug products Key benefits Authors Varun Khali , Sachin Pandey , Manoj 1 1 • A single method capable…

Pharma and biopharma Nitrosamine impurities analysis solutions guide • Find the right analytical solution for each stage of nitrosamine impurity analysis • Confidently detect and quantify genotoxic impurities in active pharmaceutical ingredients and finished drug products Contents Advancing confidence in…

Pharma and biopharma Innovation meets reliability Discover new levels of precision in your routine analysis Your partner for every step in your therapeutics journey When you’re advancing life-changing therapeutics to market, your analytical science deserves more than standard solutions. That’s…

APPLICATION NOTE 73814 HRAM LC-MS method for the determination of nitrosamine impurities in drugs Authors: Hao Yang, Thermo Fisher Scientific, San Jose, CA, US Jon Bardsley, Thermo Fisher Scientific, Hemel Hempstead, UK Min Du, Thermo Fisher Scientific, Boston, MA, US…